查看购物车
  • Traditional Chinese
  • English
欧洲医疗外骨骼市场预测（至2031年）-区域分析-按组件、类型、肢体、应用、移动性和最终用户
市场调查报告书
商品编码
1715173

欧洲医疗外骨骼市场预测（至2031年）-区域分析-按组件、类型、肢体、应用、移动性和最终用户

Europe Medical Exoskeleton Market Forecast to 2031 - Regional Analysis - by Component, Type, Extremity, Application, Mobility, and End Users
出版日期: | 出版商: The Insight Partners | 英文 117 Pages | 订单完成后即时交付

价格

2023年欧洲医疗外骨骼市场价值为1.0748亿美元，预计到2031年将达到8.5396亿美元；预计2023年至2031年的复合年增长率为29.6%。

中风和肌肉骨骼发生率不断上升推动欧洲医疗外骨骼市场

儘管医疗产业取得了进步，但中风仍然是一个主要的公共卫生问题。中风是全球第二大死因，也是导致残疾的主要原因。根据《2022 年全球中风说明书》，过去 17 年间，一生中中风的风险上升了 50%，预计每 4 人中就有 1 人会在一生中的某个时刻患上中风。 1990年至2019年间，中风发生率上升了70%，中风相关死亡人数上升了43%，中风频率上升了102%，伤残调整生命年（DALY）上升了143%。最值得注意的是，中低收入国家占世界中风负担的绝大部分（占中风相关死亡人数的 86% 和 DALY 的 89%）。 2017年，欧盟共发生112万起中风事件，953万名中风倖存者，46万例中风相关死亡，以及706万年因中风致残而损失的寿命。此外，预计2017年至2047年间，中风患者数量将增加27%，主要是由于人口老化和存活率提高。预计各国之间仍将存在差异，这表明病例管理和预防方面有进步的潜力，尤其是在东欧。因此，中风发病率的不断上升增加了对中风患者復健的外骨骼系统的需求，以帮助改善生活品质。

此外，肌肉骨骼疾病会影响个人的活动能力。肌腱炎、骨质减少、肌少症和腰背部损伤等肌肉骨骼疾病的盛行率不断上升，导致对外骨骼机器人系统的需求日益增长。根据世界卫生组织 (WHO) 的数据，全球约有 17.1 亿人患有肌肉骨骼疾病，下背部疼痛是 160 个国家的主要残疾原因。这些外骨骼可以帮助患者控制疼痛，恢復活动能力，从而提高他们的整体生活品质。因此，中风和肌肉骨骼疾病的盛行率不断上升，导致人们使用外骨骼机器人系统进行復健治疗。

欧洲医疗外骨骼市场概况

欧洲医疗外骨骼市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。该地区在全球医疗外骨骼市场占有相当大的份额，预计将实现显着的复合年增长率。该国的市场参与者正在采用合作伙伴关係和协作等无机成长策略来扩大和成长市场。 2022年8月，德国Bionic公司（智慧动力服饰开发领域的全球技术领导者）与Mubea公司（德国顶级汽车供应商）达成合作协议。透过协助世界顶级机器人外骨骼开发商进行生产，Mubea 进入了一个全新且前景广阔的未来领域。同样，2020 年 4 月，ReWalk Robotics Ltd. 宣布与德国顶级法定健康保险公司 (“SHI”)、Deutsche Angestellten-Krankenkasse - Gesundheit (“DAK-Gesundheit”) 和 Techniker Krankenkasse (“TK”) 达成协议。本协议允许任何符合资格的脊髓损伤受益人获得 ReWalk 6.0 外骨骼系统。 TK 和 DAK 分别代表德国 1,060 万和 560 万名受益人，是德国最大的两家 SHI；这些协议有望帮助德国制定外骨骼采购标准。

欧洲医疗外骨骼市场收入及预测（2031年）（百万美元）

欧洲医疗外骨骼市场细分

欧洲医疗外骨骼市场分为组件、类型、肢体、应用、移动、最终用户和国家。

根据组成部分，欧洲医疗外骨骼市场分为硬体和软体。 2023 年，硬体部分占据了欧洲医疗外骨骼市场的较大份额。

从类型来看，欧洲医疗外骨骼市场分为动力外骨骼和被动外骨骼。 2023 年，动力外骨骼领域占据了欧洲医疗外骨骼市场的较大份额。

根据肢体，欧洲医疗外骨骼市场分为下半身外骨骼、上半身外骨骼和全身外骨骼。 2023 年，下肢外骨骼领域占据欧洲医疗外骨骼市场的最大份额。

根据应用，欧洲医疗外骨骼市场分为脊髓损伤、多发性硬化症、中风、脑性麻痹、巴金森氏症等。 2023 年，脊髓损伤领域占据欧洲医疗外骨骼市场的最大份额。

就移动性而言，欧洲医疗外骨骼市场分为移动外骨骼和固定外骨骼。 2023 年，动力外骨骼领域占据了欧洲医疗外骨骼市场的较大份额。

根据最终用户，欧洲医疗外骨骼市场分为復健中心、物理治疗中心、长期照护中心、家庭护理机构等。 2023 年，復健中心部门占据欧洲医疗外骨骼市场的最大份额。

根据国家/地区，欧洲医疗外骨骼市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。 2023 年，德国占据欧洲医疗外骨骼市场的最大份额。

比奥尼克； B-Temia 公司； Cyber​​dyne公司； Ekso Bionics Holdings Inc； ExoAtlet；霍科马股份公司； Lifeward 公司； Myomo 公司； Rex Bionics 有限公司；和 Wearable Robotics SR 是欧洲医疗外骨骼市场的一些领先公司。

目录

第一章：简介

第二章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：欧洲医疗外骨骼市场-关键市场动态

  • 欧洲医疗外骨骼市场-关键市场动态
  • 市场驱动因素：
    • 策略倡议不断增加
    • 中风和肌肉骨骼疾病发生率不断上升
    • 老年人口寿命延长
  • 市场限制
    • 产品成本高且监管问题
  • 市场机会
    • 脊髓损伤盛行率不断上升
  • 未来趋势
    • 科技进步不断加快，投资不断增加
  • 驱动因素和限制因素的影响：

第五章：欧洲医疗外骨骼市场分析

  • 2021-2031年欧洲医疗外骨骼市场收入
  • 欧洲医疗外骨骼市场预测分析

第六章：欧洲医疗外骨骼市场分析-按组件

  • 硬体
  • 软体

第七章：欧洲医疗外骨骼市场分析-依类型

  • 动力外骨骼
  • 被动外骨骼

第 8 章：欧洲医疗外骨骼市场分析 - 按 Extremity

  • 下肢外骨骼
  • 上身外骨骼
  • 全身外骨骼

第九章：欧洲医疗外骨骼市场分析-按应用

  • 脊髓损伤
  • 多发性硬化症
  • 中风
  • 脑性麻痹
  • 帕金森氏症
  • 其他的

第 10 章：欧洲医疗外骨骼市场分析 - 依移动性

  • 移动外骨骼
  • 固定式外骨骼

第 11 章：欧洲医疗外骨骼市场分析 - 按最终用户

  • 復健中心
  • 物理治疗中心
  • 长期照护中心
  • 家庭护理设置
  • 其他的

第 12 章：欧洲医疗外骨骼市场-国家分析

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第 13 章：医疗外骨骼市场-产业格局

  • 概述
  • 医疗外骨骼市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 14 章：公司简介

  • Ekso Bionics Holdings Inc
  • Lifeward, Inc
  • ExoAtlet
  • Cyberdyne Inc
  • BIONIK
  • B-Temia Inc
  • Hocoma AG
  • Wearable Robotics SRL
  • Myomo Inc
  • Rex Bionics Ltd.

第 15 章：附录

Product Code: BMIRE00031138

The Europe medical exoskeleton market was valued at US$ 107.48 million in 2023 and is expected to reach US$ 853.96 million by 2031; it is estimated to register a CAGR of 29.6% from 2023 to 2031.

Growing Incidence of Stroke and Musculoskeletal Drives Europe Medical Exoskeleton Market

Despite the advancements in the medical industry, stroke continues to be a major public health issue. Stroke ranks second in the world in terms of causes of mortality and is the main cause of disability. According to the Global Stroke Factsheet 2022, the lifetime risk of having a stroke has risen by 50% in the past 17 years, with an estimated 1 in 4 people expected to experience one at some point in their lives. Between 1990 and 2019, there was a rise of 70% in the incidence of stroke, 43% in the number of stroke-related deaths, 102% in the frequency of stroke, and 143% in Disability Adjusted Life Years (DALY). The most notable aspect is that lower- and lower-middle-income countries account for the majority of the world's stroke burden (86% of stroke-related fatalities and 89% of DALYs). In the European Union, there were 1.12 million stroke incidents, 9.53 million stroke survivors, 0.46 million stroke-related deaths, and 7.06 million years of life lost due to disability from stroke in 2017. Further, the number of people living with stroke is predicted to rise by 27% between 2017 and 2047, primarily as a result of aging populations and higher survival rates. It is anticipated that differences will continue to exist between nations, indicating potential for advancements in case management and prevention, especially in Eastern Europe. Therefore, the increasing incidences of stroke have boosted the demand for exoskeleton systems for rehabilitation of stroke patients to help improve the quality of life.

In addition, musculoskeletal disorders impact the mobility of an individual. The increasing prevalence of musculoskeletal disorders, such as tendinitis, osteopenia, sarcopenia, and low back injuries, result in a growing need for exoskeletan robotic systems. According to the World Health Organization (WHO), ~1.71 billion people globally are affected by musculoskeletal diseases, and lower back pain is a leading cause of disability in 160 countries. These exoskeletons assist patients in managing their pain, as well as help regain their mobility, thereby improving their overall quality of life. Thus, the increasing prevalence of stroke and musculoskeletal disorders has led to the use of exoskeletan robotic systems for rehabilitation.

Europe Medical Exoskeleton Market Overview

The European medical exoskeleton market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant share of the global medical exoskeleton market and is expected to register a notable CAGR. Market players in the country are adopting inorganic growth strategies such as partnerships and collaborations for market expansion and growth. In August 2022, German Bionic (a global technology leader in the development of smart power suits) and Mubea (the top German automotive supplier) entered a cooperation agreement. By assisting the world's top developer of robotic exoskeletons in production, Mubea tapped into a new and quite promising future sector. Similarly, in April 2020, ReWalk Robotics Ltd. announced the national agreement with top German Statutory Health Insurers ("SHI"), Deutsche Angestellten-Krankenkasse - Gesundheit ("DAK-Gesundheit"), and Techniker Krankenkasse ("TK"). This agreement can permit any eligible beneficiary with a spinal cord injury to get a ReWalk 6.0 exoskeleton system. TK and DAK, representing 10.6 million and 5.6 million beneficiaries in Germany, respectively, are two of the largest SHIs in the country; these agreements are expected to help set the standard for exoskeleton procurement in Germany.

Europe Medical Exoskeleton Market Revenue and Forecast to 2031 (US$ Million)

Europe Medical Exoskeleton Market Segmentation

The Europe medical exoskeleton market is categorized into component, type, extremity, application, mobility, end users, and country.

By component, the Europe medical exoskeleton market is bifurcated into hardware and software. The hardware segment held a larger share of the Europe medical exoskeleton market share in 2023.

In terms of type, the Europe medical exoskeleton market is bifurcated into powered exoskeleton and passive exoskeleton. The powered exoskeleton segment held a larger share of the Europe medical exoskeleton market share in 2023.

Based on extremity, the Europe medical exoskeleton market is segmented into lower body exoskeleton, upper body exoskeleton, and full body exoskeleton. The lower body exoskeleton segment held the largest share of the Europe medical exoskeleton market share in 2023.

By application, the Europe medical exoskeleton market is segmented into spinal cord injury, multiple sclerosis, stroke, cerebral palsy, Parkinson's Disease, and others. The spinal cord injury segment held the largest share of the Europe medical exoskeleton market share in 2023.

In terms of mobility, the Europe medical exoskeleton market is bifurcated into mobile exoskeleton and stationary exoskeleton. The powered exoskeleton segment held a larger share of the Europe medical exoskeleton market share in 2023.

By end users, the Europe medical exoskeleton market is segmented into rehabilitation centers, physiotherapy centers, long term care centers, homecare settings, and others. The rehabilitation centers segment held the largest share of the Europe medical exoskeleton market share in 2023.

Based on country, the Europe medical exoskeleton market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany segment held the largest share of Europe medical exoskeleton market in 2023.

BIONIK; B-Temia Inc; Cyberdyne Inc; Ekso Bionics Holdings Inc; ExoAtlet; Hocoma AG; Lifeward, Inc; Myomo Inc; Rex Bionics Ltd.; and Wearable Robotics SR are some of the leading companies operating in the Europe medical exoskeleton market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Europe Medical Exoskeleton Market - Key Market Dynamics

  • 4.1 Europe Medical Exoskeleton Market - Key Market Dynamics
  • 4.2 Market Drivers:
    • 4.2.1 Rising Number of Strategic Initiatives
    • 4.2.2 Growing Incidence of Stroke and Musculoskeletal
    • 4.2.3 Increasing Longevity of Aging Population
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Product and Regulatory Concerns
  • 4.4 Market Opportunities
    • 4.4.1 Increasing Prevalence of SCI
  • 4.5 Future Trends
    • 4.5.1 Increasing Technological Advancements and Rising Investments
  • 4.6 Impact of Drivers and Restraints:

5. Medical Exoskeleton Market - Europe Analysis

  • 5.1 Europe Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
  • 5.2 Europe Medical Exoskeleton Market Forecast Analysis

6. Europe Medical Exoskeleton Market Analysis - by Component

  • 6.1 Hardware
    • 6.1.1 Overview
    • 6.1.2 Hardware: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.2 Software
    • 6.2.1 Overview
    • 6.2.2 Software: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Medical Exoskeleton Market Analysis - by Type

  • 7.1 Powered Exoskeleton
    • 7.1.1 Overview
    • 7.1.2 Powered Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Passive Exoskeleton
    • 7.2.1 Overview
    • 7.2.2 Passive Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Medical Exoskeleton Market Analysis - by Extremity

  • 8.1 Lower Body Exoskeleton
    • 8.1.1 Overview
    • 8.1.2 Lower Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Upper Body Exoskeleton
    • 8.2.1 Overview
    • 8.2.2 Upper Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Full Body Exoskeleton
    • 8.3.1 Overview
    • 8.3.2 Full Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Medical Exoskeleton Market Analysis - by Application

  • 9.1 Spinal Cord Injury
    • 9.1.1 Overview
    • 9.1.2 Spinal Cord Injury: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Multiple Sclerosis
    • 9.2.1 Overview
    • 9.2.2 Multiple Sclerosis: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Stroke
    • 9.3.1 Overview
    • 9.3.2 Stroke: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Cerebral Palsy
    • 9.4.1 Overview
    • 9.4.2 Cerebral Palsy: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Parkinson's Diseases
    • 9.5.1 Overview
    • 9.5.2 Parkinson's Diseases: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

10. Europe Medical Exoskeleton Market Analysis - by Mobility

  • 10.1 Mobile Exoskeleton
    • 10.1.1 Overview
    • 10.1.2 Mobile Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Stationary Exoskeleton
    • 10.2.1 Overview
    • 10.2.2 Stationary Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

11. Europe Medical Exoskeleton Market Analysis - by End Users

  • 11.1 Rehabilitation Centers
    • 11.1.1 Overview
    • 11.1.2 Rehabilitation Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Physiotherapy Centers
    • 11.2.1 Overview
    • 11.2.2 Physiotherapy Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Long Term Care Centers
    • 11.3.1 Overview
    • 11.3.2 Long Term Care Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Homecare Settings
    • 11.4.1 Overview
    • 11.4.2 Homecare Settings: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.5 Others
    • 11.5.1 Overview
    • 11.5.2 Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)

12. Europe Medical Exoskeleton Market - Country Analysis

  • 12.1 Europe Medical Exoskeleton Market
    • 12.1.1 Europe Medical Exoskeleton Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 Germany: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.1.1.1 Germany: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.1.1.1.1 Germany: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.1.2 Germany: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.1.3 Germany: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.1.4 Germany: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.1.5 Germany: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.1.6 Germany: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.2 United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 United Kingdom: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.2.1.1 United Kingdom: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.2.1.1.1 United Kingdom: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.2.2 United Kingdom: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.2.3 United Kingdom: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.2.4 United Kingdom: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.2.5 United Kingdom: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.2.6 United Kingdom: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.3 France: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 France: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.3.1.1 France: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.3.1.1.1 France: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.3.2 France: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.3.3 France: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.3.4 France: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.3.5 France: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.3.6 France: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.4 Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.4.1 Italy: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.4.1.1 Italy: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.4.1.1.1 Italy: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.4.2 Italy: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.4.3 Italy: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.4.4 Italy: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.4.5 Italy: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.4.6 Italy: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.5 Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.5.1 Spain: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.5.1.1 Spain: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.5.1.1.1 Spain: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.5.2 Spain: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.5.3 Spain: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.5.4 Spain: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.5.5 Spain: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.5.6 Spain: Medical Exoskeleton Market Breakdown, by End Users
      • 12.1.1.6 Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.6.1 Rest of Europe: Medical Exoskeleton Market Breakdown, by Component
        • 12.1.1.6.1.1 Rest of Europe: Medical Exoskeleton Market Breakdown, by Hardware
        • 12.1.1.6.1.1.1 Rest of Europe: Medical Exoskeleton Market Breakdown, by Actuators
        • 12.1.1.6.2 Rest of Europe: Medical Exoskeleton Market Breakdown, by Type
        • 12.1.1.6.3 Rest of Europe: Medical Exoskeleton Market Breakdown, by Extremity
        • 12.1.1.6.4 Rest of Europe: Medical Exoskeleton Market Breakdown, by Application
        • 12.1.1.6.5 Rest of Europe: Medical Exoskeleton Market Breakdown, by Mobility
        • 12.1.1.6.6 Rest of Europe: Medical Exoskeleton Market Breakdown, by End Users

13. Medical Exoskeleton Market - Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Medical Exoskeleton Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Ekso Bionics Holdings Inc
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Lifeward, Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 ExoAtlet
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Cyberdyne Inc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 BIONIK
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 B-Temia Inc
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Hocoma AG
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Wearable Robotics SRL
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Myomo Inc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Rex Bionics Ltd.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Medical Exoskeleton Market Segmentation
  • Table 2. Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Europe Medical Exoskeleton Market, by Hardware - Revenue and Forecast to 2031 (USD Million)
  • Table 4. Europe Medical Exoskeleton Market, by Actuators - Revenue and Forecast to 2031 (USD Million)
  • Table 5. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 6. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 7. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 8. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 9. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 10. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 11. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 12. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 13. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 14. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 15. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 16. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 17. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 18. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 19. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 20. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 21. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 22. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 23. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 24. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 25. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 26. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 27. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 28. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 29. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 30. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 31. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 32. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 33. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 34. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 35. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 36. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 37. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 38. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 39. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 40. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 41. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 42. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 43. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 44. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 45. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Component
  • Table 46. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Hardware
  • Table 47. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Actuators
  • Table 48. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 49. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Extremity
  • Table 50. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 51. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by Mobility
  • Table 52. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million) - by End Users
  • Table 53. Recent Organic Growth Strategies in Medical Exoskeleton Market
  • Table 54. Recent Inorganic Growth Strategies in the Medical Exoskeleton Market
  • Table 55. Glossary of Terms, Medical Exoskeleton Market

List Of Figures

  • Figure 1. Europe Medical Exoskeleton Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Medical Exoskeleton Market Revenue (US$ Million), 2021-2031
  • Figure 4. Europe Medical Exoskeleton Market Share (%) - by Component (2023 and 2031)
  • Figure 5. Hardware: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 6. Software: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Europe Medical Exoskeleton Market Share (%) - by Type (2023 and 2031)
  • Figure 8. Powered Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Passive Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Europe Medical Exoskeleton Market Share (%) - by Extremity (2023 and 2031)
  • Figure 11. Lower Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Upper Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Full Body Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Europe Medical Exoskeleton Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Spinal Cord Injury: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Multiple Sclerosis: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Stroke: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Cerebral Palsy: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Parkinson's Diseases: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Europe Medical Exoskeleton Market Share (%) - by Mobility (2023 and 2031)
  • Figure 22. Mobile Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Stationary Exoskeleton: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Europe Medical Exoskeleton Market Share (%) - by End Users (2023 and 2031)
  • Figure 25. Rehabilitation Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Physiotherapy Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Long Term Care Centers: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Homecare Settings: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Others: Europe Medical Exoskeleton Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Europe Medical Exoskeleton Market, by Key Country - Revenue (2023) (US$ Million)
  • Figure 31. Europe Medical Exoskeleton Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 32. Germany: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. United Kingdom: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. France: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. Italy: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Spain: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. Rest of Europe: Medical Exoskeleton Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Growth Strategies in Medical Exoskeleton Market